Designing and manufacturing efficient vaccines against coronavirus disease 2019 (COVID‐
19) is a major objective. In this systematic review, we aimed to evaluate the most important …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has thrown a challenge to
the scientific community. Several interventions to stop or limit the spread of infection have …

Abstract Coronavirus disease 2019 (COVID-19) has caused millions of deaths, and serious
consequences to public health, economies and societies. Rapid responses in vaccine …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …

ABSTRACT As of September 2021, 117 COVID-19 vaccines are in clinical development,
and 194 are in preclinical development as per the World Health Organization (WHO) …

The coronavirus disease 2019 (COVID-19) pandemic has threatened global health and
prompted the need for mass vaccination. We aimed to assess the efficacy and effectiveness …

This systematic review and meta-analysis was conducted to compare the safety and efficacy
of 2019 novel coronavirus disease (COVID-19) vaccines according to vaccine platform and …

Background Various modalities of vaccines against coronavirus disease 2019 (COVID-19),
based on different platforms and immunization procedures, have been successively …

Vaccines against coronavirus disease 2019 (COVID‐19) have been discovered within a
very small duration of time as compared to the traditional way for the development of …

Objective: To systematically evaluate the effectiveness and safety of the SARS‐CoV‐2
vaccines currently undergoing clinical trials. Methods: PubMed, EMBASE, and Cochrane …